In a study in Central Asia, HSYA was found to lower the expression of Foxp3 and Rorγt in tumour tissue in the spleen, enhance immunity in mice, and reduce liver tissue damage due to cisplatin chemotherapy, thereby regulating the tumour immune micro-environment and exerting an anti-cancer effect. The gene discussed is FOXP3; the disease is neoplasm.